iHEART-SA Intervention Study

Hypertension Clinical Trial

— iHEART-SA  

Official title:

The Integrating HIV and hEART Health in South Africa Intervention Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05846503
• Other study ID #: iHEART-SA IS
• Status: Recruiting
• Phase: N/A
• Start date: June 1, 2023
• Est. completion date: August 31, 2025

Study information

• Verified date: May 2023
• Source: University of Witwatersrand, South Africa
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Using qualitative data during the formative phase the IHEART-SA research study filled deficiencies in knowledge regarding: 1) what barriers exist to integrating hypertension care within the HIV care setting in South Africa and, 2) how a hypertension care intervention can be adapted to effectively and sustainably function in this care setting. These data have been used to design a context-relevant intervention package for implementation in the next phase of effectiveness-implementation testing, answering the research question: How does an intervention aimed at enhancing hypertension diagnosis and management in people living with HIV improve the delivery of guideline-recommended care in primary healthcare clinics in Gauteng, South Africa, and hypertension control among patients?

The study will use an effectiveness-implementation study design. This design allows for the testing of strategies to promote integration of proven interventions in real-world practice (i.e., implementation strategies), while simultaneously assessing clinical effectiveness (i.e., patient level outcomes). For this the study will use a randomized cluster stepped-wedge study design where nine clinics (grouped in clusters of three) will be assigned to a time at which they initiate the intervention.

Description:

Investigational interventions:

Implementation facilitation of improved hypertension screening and management in the HIV care setting through the iHEART-SA intervention model comprising:

1. Information management system

2. Task shifting

3. Audit and feedback

4. Healthcare worker education and training

5. Patient education and support

Study design:

Cluster randomized stepped wedge effectiveness-implementation type 2 hybrid

Study objectives:

1. Assess the short- and long-term effects of an implementation strategy (i.e., healthcare worker intervention) on the adoption and implementation of hypertension screening and treatment among healthcare workers

2. Assess the short- and long-term effects of a clinical intervention (i.e., patient-level intervention) on patient blood pressure control among patients living with HIV and hypertension

Duration of participation: 27 months Study duration: 37 months

Intervention audience:

1. Healthcare workers (nurses and doctors)

2. Adult patients living with HIV from the 9 primary healthcare clinics

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 2160
• Est. completion date: August 31, 2025
• Est. primary completion date: May 31, 2025
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

Healthcare workers:

1. Adult >18 years men and women working in clinical roles at the selected clinics

2. Provide informed consent (only those participating in the qualitative components)

Patients:

1. Adults >18 years living with HIV and hypertension

2. Enrolled in the study clinic

3. Willing and able to provide informed consent

Exclusion Criteria:

Patients:

1. Unable or unwilling to provide informed consent

2. Planning to relocate or change service providers/clinics

Related Conditions & MeSH terms

• HIV
• Hypertension

Intervention

Behavioral:
• 1. Quality and info management system
The intervention package prioritizes information and quality management with a focus on HTN screening, diagnosis, and treatment. From the point-of-care, flow charts placed in the patient file will ensure that vitals are performed in accordance with national guidelines. The care coordinator will present data to clinic staff in multi-disciplinary meetings, providing an opportunity for programmatic feedback and discussion. Patients will be encouraged to complete the vital signs measurements at each clinic visit. They will be provided with their BP readings and given info about what their reading means. They will be issued with pocket sized color coded booklets providing info on the measurement and what to do to control their BP. Task shifting: A care coordinator will be the champion of the intervention package for the clinic. All staff will receive apt training on how to use the patient flow chart, info management system and how to respond to abnormal BP values.

Locations

Country	Name	City	State
South Africa	Sunnyside Office Park	Johannesburg	Gauteng

Sponsors (4)

Lead Sponsor	Collaborator
University of Witwatersrand, South Africa	Emory University, Massachusetts General Hospital, UMC Utrecht

Country where clinical trial is conducted

South Africa, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Healthcare worker	Difference in percentage of patient visits with recorded BP measurement between intervention and control clinics	24 months
Primary	Patient	Difference in mean systolic BP between the intervention and control conditions	12 months
Secondary	Healthcare worker implementation	% of healthcare workers who implement the iHEART-SA package as intended at month 12 and month 24	24 months
Secondary	Healthcare worker adoption	Participation rate and representativeness of healthcare workers who adopt the BP screening and treatment model	24 months
Secondary	Healthcare worker maintenance - BP measurement	% of patients who had a BP measurement done at every clinic visit	12 months
Secondary	Healthcare worker satisfaction	% of healthcare workers who are satisfied with all components of the intervention	24 months
Secondary	Healthcare worker costing	Costs of each intervention components will be recorded as healthcare worker time, material costs, and healthcare/monitoring equipment	27 months
Secondary	Patient adoption	Participation rate and representativeness of eligible patients who consent to chart review	24 months
Secondary	Patient satisfaction	% of patients who are satisfied with all components of the intervention	24 months
Secondary	Healthcare worker maintenance - BP management	% of patients who had an elevate BP managed at every visit post intervention	12 months